Literature DB >> 7780970

A mutator phenotype characterizes one of two complementation groups in human cells tolerant to methylation damage.

G Aquilina1, P Hess, S Fiumicino, S Ceccotti, M Bignami.   

Abstract

Sixty % of clones isolated from HeLa cells treated with toxic concentrations of a methylating carcinogen showed increased resistance to the cytotoxicity of N-methyl-N-nitrosourea. D37 values were 6- to 100-fold higher than in the parental cell population. The absence of detectable levels of the repair enzyme O6-methylguanine-DNA methyltransferase indicated that the resistant clones were able to tolerate the presence of O6-methylguanine in their DNA. Analysis of N-methyl-N-nitrosourea survival in the hybrids between tolerant clones and HeLa cells showed that tolerance can be either recessive or codominant. Fusion between tolerant clones indicated two complementation groups. We measured spontaneous mutation rates at microsatellites and at the hypoxanthine-guanine phosphoribosyl transferase (hprt) locus in several tolerant clones. All the clones of Complementation Group I showed unstable microsatellites and 4-8-fold increases in mutation rates at hprt. No significant alterations in spontaneous mutation rates were found in clones of Complementation Group II. The data indicate that tolerance to methylation damage can be conferred by alterations in at least two different gene products and that one of the two groups has the mutator phenotype typical of mismatch correction defective cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7780970

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

1.  Preparation of DNA substrates for in vitro mismatch repair.

Authors:  H Wang; J B Hays
Journal:  Mol Biotechnol       Date:  2000-06       Impact factor: 2.695

2.  Multiple mutations and frameshifts are the hallmark of defective hPMS2 in pZ189-transfected human tumor cells.

Authors:  S Ceccotti; C Ciotta; G Fronza; E Dogliotti; M Bignami
Journal:  Nucleic Acids Res       Date:  2000-07-01       Impact factor: 16.971

3.  Human MutSalpha recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct.

Authors:  D R Duckett; J T Drummond; A I Murchie; J T Reardon; A Sancar; D M Lilley; P Modrich
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

4.  DHFR/MSH3 amplification in methotrexate-resistant cells alters the hMutSalpha/hMutSbeta ratio and reduces the efficiency of base-base mismatch repair.

Authors:  J T Drummond; J Genschel; E Wolf; P Modrich
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

5.  hMutSalpha- and hMutLalpha-dependent phosphorylation of p53 in response to DNA methylator damage.

Authors:  D R Duckett; S M Bronstein; Y Taya; P Modrich
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.